Wound Retractors/Protectors

Award

Buyers

Value

£985,000

Suppliers

Classifications

  • Operating theatre devices and instruments
  • Medical equipments

Tags

  • award
  • contract

Published

2 weeks ago

Description

Wound Retractors/Protectors

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Total Patient Assessment Device Solutions Tender Notice

NHS Supply Chain seeks to establish a Framework Agreement for Total Patient Assessment Device Solution Products under which it will be entitled to purchase supplies and/or services which it will make available for purchase by 1) any NHS Trust; 2) any other NHS entity; 3) any government department, agency or other statutory body and/or 4) any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it. This includes the following requirements which have been sub-divided into Lots: Lot 1 - Blood Pressure Monitoring with Blood Pressure Cuffs Lot 2 - Thermometer Devices and Related Consumables Lot 3 - Patient Weighing Scales and Measuring Devices Lot 4 - Patient Assessment Devices and Kits Lot 5 - Personal Health Monitors and Kits It is anticipated that initial expenditure will be in the region of £23,900,000 to £25,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated value over the 2-year Framework Agreement will be in the region of £47,800,000. There will be an option to extend the Framework for a further 2 years. If the extension period will be utilised, then the total value of the Framework across the 4 year would be approximately £95,600,000. Preliminary market engagement was carried out during PCR 2015, with a Prior Information Notice being published. The identifier codes for the Prior information Notice are as follows: Notice identifier: 2024/S 000-018940 Procurement identifier (OCID): ocds-h6vhtk-04713a

Katy Reed

Katy Reed

Published 2 days ago
Open

LSL/MED/0174 - The Supply and support of Emergency Patient Trolleys - Tender Notice - PA23

Team Leidos are proud to be delivering the logistics commodities and services transformation (LCS(T)) Delivery partner contracts (LCS (T)/0001 dated 16.4.2015) on behalf of the UK Ministry of Defence (MoD) (the ‘Prime Contract’). Delivery of other parts of the LCS(T) contract are delivered by Leidos Europe Ltd (LEL) and other partners (together ‘Team Leidos’). This requirement is subject to the Public Procurement Regulations and respective advertising action. The Team Leidos MERP, which forms part of Leidos Supply Ltd. is tendering for the supply of Emergency Patient Trolleys on behalf of the UK MoD. The total estimated value for this Framework Agreement will be between £1,120,000 and £2,800,000, with a total length of 4 Years. In addition, please note that as a framework agreement there is no guarantee of business. If this is of further interest, please register on our eProcurement system, Jaggaer: https://leidossupply.app.jaggaer.com Bidders will be able to register on the system, and once registered they can express their interest and complete their bid on there. Should Bidders have any queries regarding the system, please contact the support team on the front page of the Jaggaer website, where it says 'Need assistance?', for help. Anyqueries regarding the tender itself, as opposed to the system, should be directed through Jaggaer's messaging centre.

Katy Reed

Katy Reed

Published 2 days ago
Open

Supply and Support of Complete Antibody Quantification Testing Systems

The RCI laboratories in NHSBT provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig This specialised test conducted in 4 of the 7 RCI laboratories (namely Birmingham, Colindale, Liverpool and Newcastle). RCI processes approximately 10,000 tests annually. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals.

Katy Reed

Katy Reed

Published 5 days ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

Regional Business Services Organisation Procurement and Logistics Service

Body governed by public law

Timeline complete

Publish
Bid
Evaluate
Award
Complete